Coccidioidomycosis (DC 6835)

Body system: Respiratory SystemRegulation: 38 CFR § 4.97

Coccidioidomycosis is a fungal infection caused by inhaling Coccidioides spores from desert soil, endemic to the southwestern United States, particularly Arizona, central California (San Joaquin Valley), and parts of Nevada, New Mexico, Texas, and Utah. The VA rates this condition under the General Rating Formula for Mycotic Lung Disease (38 CFR § 4.97) from 0% to 100%: 100% with persistent fever, weight loss, night sweats, or massive hemoptysis; 50% requiring chronic suppressive antifungal therapy with no more than minimal symptoms; 30% with minimal symptoms but no need for suppressive therapy; 0% for healed inactive lesions. Per a CFR Note specific to DC 6835: when service connection is at issue without in-service records, the VA considers service in the endemic southwestern US plus absence of prolonged residence there before or after service as the deciding factor.

Rating levels

  • 100% — You qualify for 100% if your chronic pulmonary fungal infection (mycosis) causes persistent fever, weight loss, night sweats, or massive hemoptysis (coughing up large amounts of blood). Any one of these systemic findings is sufficient. The 100% rating recognizes the severe constitutional impact of a poorly controlled chronic pulmonary fungal infection.
  • 50% — You qualify for 50% if your chronic pulmonary mycosis requires ONGOING SUPPRESSIVE ANTIFUNGAL THERAPY (typically long-term oral antifungals like itraconazole, voriconazole, or fluconazole) to keep the infection under control, with no more than minimal residual symptoms such as occasional minor hemoptysis or productive cough. The key distinguishing feature is the need for continued medication to prevent progression.
  • 30% — You qualify for 30% if your chronic pulmonary mycosis causes minimal but ongoing symptoms such as occasional minor hemoptysis (small amounts of blood in sputum) or productive cough, but you do NOT require continuous suppressive antifungal therapy. The infection is stable enough that medication is not needed to prevent worsening.
  • 0% — You qualify for 0% if your prior pulmonary mycosis has healed, the lesions are inactive, and you have no current symptoms. The 0% rating confirms service connection but does not pay compensation by itself; it preserves the basis for service connection if symptoms recur or new residual problems develop.
  • -1% — The coccidioidomycosis Note matters for SERVICE CONNECTION, not the rating ladder itself. The primary infection has a short incubation (up to 21 days), and dissemination usually appears within 6 months, but delayed dissemination years later does happen. If you lack a service-era record of the disease, the VA looks at whether you served in the southwestern United States where coccidioidomycosis is endemic (parts of California, Arizona, Nevada, New Mexico, Texas, and Utah) AND whether you have NOT had prolonged residence in those endemic areas before or after service. Those two factors together can serve as the basis for granting service connection in the absence of in-service records.

Disclaimer: This tool is for informational purposes only and is not legal or medical advice. Always consult with your VSO representative or a qualified veterans benefits attorney for guidance on your specific claim.